Patents Examined by B. Hazel
  • Patent number: 4111924
    Abstract: A novel method for removal of protective group(s) from an amino acid or peptide having thiol group(s) protected with p-methoxybenzyl, 1-adamantyl or t-butyl group by treating the protected amino acid or peptide with the mercuric salt of acetic acid or halogenoacetic acid, the removal being effected selectively and very smoothly in a good yield under extremely mild conditions without giving any undesirable influence upon other functional or protective group(s).
    Type: Grant
    Filed: June 13, 1977
    Date of Patent: September 5, 1978
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Masahiko Fujino, Osamu Nishimura, Chieko Kitada
  • Patent number: 4087390
    Abstract: The tetradecapeptides ##STR1## in which Y is L-Asn or L-Ala are described along with corresponding non-toxic pharmaceutically-acceptable acid addition salts as well as intermediates useful in the synthesis of the tetradecapeptides. These tetradecapeptides as well as their pharmaceutically-acceptable acid addition salts exhibit various activities including inhibition of the release of gastric acid.
    Type: Grant
    Filed: February 2, 1977
    Date of Patent: May 2, 1978
    Assignee: Eli Lilly and Company
    Inventor: James E. Shields
  • Patent number: 4076659
    Abstract: The tetradecapeptide ##STR1## is described along with corresponding non-toxic pharmaceutically-acceptable acid addition salts as well as intermediates useful in the synthesis of the tetradecapeptide. This tetradecapeptide as well as its pharmaceutically acceptable acid addition salts inhibit the release of growth hormone and the release of gastric acid.
    Type: Grant
    Filed: March 17, 1976
    Date of Patent: February 28, 1978
    Assignee: Eli Lilly and Company
    Inventor: James E. Shields